CHELSEY GALLEGOS: Open Payments
NPI 1265149165 · PONTE VEDRA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 34 payments from 10 companies in 2025. Trend: 2023 $1,538 · 2024 $1,642 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $148 |
| GENZYME CORPORATION | 5 | $113 |
| Janssen Biotech, Inc. | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $39 |
| LEO Pharma Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Almirall LLC | 1 | $17 |
Products named: DUPIXENT, TREMFYA, BOTOX, SKYRIZI, Cabtreo, ANZUPGO, NEMLUVIO, Sotyktu.
Industry payments across FL — which companies pay providers there.
